Search - tctmd.com

Displaying 21 - 40 of 102

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Presentation TCT Abstracts Posters 2019

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Presenter: Ahmad Al-Abdouh

October 06, 2019

Presentation TCT Abstracts Posters 2019

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Presenter: Yuichi Ozaki

September 29, 2019

Presentation TCT 2019

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Presenter: Robert Bonow

September 28, 2019

Presentation TCT 2019

Remaining Data Gaps After the Low-Risk TAVR RCTs

Presenter: Michael Borger

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Presenter: Michael Reardon

September 26, 2019

Presentation TCT 2019

TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions

Presenter: Toby Rogers

September 25, 2019

Presentation TCT 2019

The Clinical Evidence: Extreme- to Low-Risk Patients

Presenter: Michael Reardon

September 25, 2019

Presentation TVT 2019

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

Reactions From the Surgical Community

Presenter: Patrick McCarthy

June 13, 2019

Presentation TVT 2019

Reactions From the Cardiology Community

Presenter: Blase Carabello

June 13, 2019

Presentation TVT 2019

Highlights From the CoreValve Low-Risk Trial

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

Highlights From the PARTNER 3 Low-Risk Trial

Presenter: Michael Mack

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Presentation TVT 2019

The Evolut Low-Risk Randomized Trial

Presenter: Steven Yakubov

June 13, 2019

Presentation TVT 2019

Meta-Analysis of 1-Year Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis

Presenter: Aaqib H Malik

June 13, 2019

Presentation TVT 2019

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

Presenter: Tsuyoshi Kaneko

June 12, 2019

Presentation SIF 2019

My Prediction on TAVR in Low Risk Patients

Presenter: Kendra J. Grubb

March 30, 2019

Presentation ACC 2019

Primary Results From the Evolut Low Risk Trial

Presenter: Michael J. Reardon

March 17, 2019

Presentation CRT 2019

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

Presenter: Ron Waksman

March 05, 2019

Advertisement

Show me the Data: Key Clinical Trials of 2019

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Remaining Data Gaps After the Low-Risk TAVR RCTs

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions

The Clinical Evidence: Extreme- to Low-Risk Patients

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Reactions From the Surgical Community

Reactions From the Cardiology Community

Highlights From the CoreValve Low-Risk Trial

Highlights From the PARTNER 3 Low-Risk Trial

The PARTNER 3 Low-Risk Randomized Trial

The Evolut Low-Risk Randomized Trial

Meta-Analysis of 1-Year Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis

Low-Risk Approval: Who Isn’t a Candidate for TAVR?

My Prediction on TAVR in Low Risk Patients

Primary Results From the Evolut Low Risk Trial

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content